Web8 apr. 2024 · InflaRx (NASDAQ:IFRX – Get Rating) had its price target boosted by HC Wainwright from $6.00 to $10.00 in a research report report published on Wednesday, ... WebIFRX-Small-Talk - Barolo schreibt: Wenn wir mit über 4 € ins Wochenende gehen wäre ich ganz zufrieden. Nächste Woche dann weiter mit schönen kontinuierlic. DAX ±0,00 % MDAX ±0,00 %
Inflarx NV (IFRX) Defended at Raymond James
Web12 apr. 2024 · A number of research firms have changed their ratings and price targets for InflaRx (NASDAQ: IFRX): 4/5/2024 – InflaRx had its price target raised by analysts at … Web8 sep. 2024 · Raymond James Reaffirms Their Buy Rating on InflaRx (IFRX) • TipRanks • 11/10/2024 04:36:12 PM H.C. Wainwright Keeps Their Buy Rating on InflaRx (IFRX) • TipRanks • 11/10/2024 11:16:02 AM Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/09/2024 12:55:15 PM daniels coffee and more
InflaRx Announces Public Offering of Ordinary Shares IFRX Stock …
Web06-2024-InflaRx to Present at the Raymond James Human Health Innovation Conference Jena, Germany, June 17, 2024 – InflaRx N.V. (Nasdaq: IFRX), a clinical-stage … Web19 jul. 2024 · Raymond James analyst Steven Seedhouse disagrees with InflaRx's conclusion that data support further development of IFX-1 in hidradenitis suppurativa. … Web5 aug. 2024 · Raymond James Reaffirms Their Buy Rating on InflaRx (IFRX) • TipRanks • 11/10/2024 04:36:12 PM H.C. Wainwright Keeps Their Buy Rating on InflaRx (IFRX) • TipRanks • 11/10/2024 11:16:02 AM Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/09/2024 12:55:15 PM daniels concrete redding